Alkaloids isolated from natural herbs as the anticancer agents

Evidence-based Complementary and Alternative Medicine

Volumn 2012, Issue , 2012, Pages

  Lu, Jin Jian ^a   Bao, Jiao Lin ^a   Chen, Xiu Ping ^a   Huang, Min ^a   Wang, Yi Tao ^a  

^a China Macau University of Science and Technology Zhuhai MUST Science and Technology Research Institute   (Macao)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; BERBERINE; CAMPTOTHECIN; CHELERYTHRINE; CHELIDONINE; DOXORUBICIN; EVODIAMINE; FAGARONINE; HERBACEOUS AGENT; LYCORINE; MATRINE; NITIDINE; PIPERINE; SANGUINARINE; SOLANINE; SOPHOCARPINE; TETRANDRINE; TRIGONELLINE; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE;

ANTIANGIOGENIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; BREAST CANCER; CANCER CELL; CANCER INHIBITION; CELL CYCLE ARREST; COLON CARCINOMA; CONCENTRATION RESPONSE; CYTOTOXICITY; DIABETES MELLITUS; DIARRHEA; DRUG ISOLATION; DRUG STRUCTURE; HEART ARRHYTHMIA; HERB; HUMAN; IN VITRO STUDY; IN VIVO STUDY; METASTASIS; NEURASTHENIA; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN EXPRESSION; REVIEW; SARCOMA; SIGNAL TRANSDUCTION; TERATOCARCINOMA;

EID: 84866981349     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2012/485042     Document Type: Review

References (173)

1. Wang Z. T., Liang G. Y., Zhong Yao Hua Xue 2009 Shanghai Scientific & Technical
2. Lee M. R., The history of Ephedra (ma-huang). Journal of the Royal College of Physicians of Edinburgh 2011 41 1 78 84 2-s2.0-79959512168 10.4997/JRCPE.2011.116
3. Benyhe S., Morphine: new aspects in the study of an ancient compound. Life Sciences 1994 55 13 969 979 2-s2.0-0027937431 10.1016/0024-3205(94)00631-8 (Pubitemid 24269390)
4. Li W., Shao Y., Hu L., Zhang X., Chen Y., Tong L., Li C., Shen X., Ding J., BM6, a new semi-synthetic Vinca alkaloid, exhibits its potent in vivo anti-tumor activities via its high binding affinity for tubulin and improved pharmacokinetic profiles. Cancer Biology and Therapy 2007 6 5 787 794 2-s2.0-34548228429 (Pubitemid 47328363)
5. Huang M., Gao H., Chen Y., Zhu H., Cai Y., Zhang X., Miao Z., Jiang H., Zhang J., Shen H., Lin L., Lu W., Ding J., Chimmitecan, a novel 9-substituted camptothecin, with improved anticancer pharmacologic profiles in vitro and in vivo. Clinical Cancer Research 2007 13 4 1298 1307 2-s2.0-33947246636 10.1158/1078-0432.CCR-06-1277 (Pubitemid 46424071)
6. Chen J., ZHao H., Wang X., Lee F. S. C., Yang H., Zheng L., Analysis of major alkaloids in Rhizoma coptidis by capillary electrophoresis-electrospray- time of flight mass spectrometry with different background electrolytes. Electrophoresis 2008 29 10 2135 2147 2-s2.0-44649092127 10.1002/elps.200700797 (Pubitemid 351781210)
7. Yu H. H., Kim K. J., Cha J. D., Kim H. K., Lee Y. E., Choi N. Y., You Y. O., Antimicrobial activity of berberine alone and in combination with ampicillin or oxacillin against methicillin-resistant Staphylococcus aureus. Journal of Medicinal Food 2005 8 4 454 461 2-s2.0-31044440371 10.1089/jmf.2005.8.454
8. Lau C. W., Yao X. Q., Chen Z. Y., Ko W. H., Huang Y., Cardiovascular actions of berberine. Cardiovascular Drug Reviews 2001 19 3 234 244 2-s2.0-0035672517 (Pubitemid 34019907)
9. Han J., Lin H., Huang W., Modulating gut microbiota as an anti-diabetic mechanism of berberine. Medical Science Monitor 2011 17 7 RA164 RA167 2-s2.0-79959964544
10. Kulkarni S. K., Dhir A., Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytotherapy Research 2010 24 3 317 324 2-s2.0-77349115762 10.1002/ptr.2968
11. Ji Y. B., Active Ingredients of Traditional Chinese Medicine: Pharmacology and Application 2011 People's Medical Publishing Hourse Cp., LTD
12. Sun Y., Xun K., Wang Y., Chen X., A systematic review of the anticancer properties of berberine, a natural product from Chinese herbs. Anti-Cancer Drugs 2009 20 9 757 769 2-s2.0-70349085370 10.1097/CAD.0b013e328330d95b
13. Diogo C. V., Machado N. G., Barbosa I. A., Serafim T. L., Burgeiro A., Oliveira P. J., Berberine as a promising safe anti-cancer agentis there a role for mitochondria? Current Drug Targets 2011 12 6 850 859 2-s2.0-79955619830 10.2174/138945011795528930
14. Tan W., Lu J., Huang M., Anti-cancer natural products isolated from chinese medicinal herbs. Chinese Medicine 2011 6 1 27
15. Eom K. S., Kim H. J., So H. S., Park R., Kim T. Y., Berberine-induced apoptosis in human glioblastoma T98G Cells Is mediated by endoplasmic reticulum stress accompanying reactive oxygen species and mitochondrial dysfunction. Biological and Pharmaceutical Bulletin 2010 33 10 1644 1649 2-s2.0-77957998671
16. Burgeiro A., Gajate C., Dakir E. H., Villa-Pulgarín J. A., Oliveira P. J., Mollinedo F., Involvement of mitochondrial and B-RAF/ERK signaling pathways in berberine-induced apoptosis in human melanoma cells. Anti-Cancer Drugs 2011 22 6 507 518 2-s2.0-79958289658 10.1097/CAD. 0b013e32834438f6
17. Wang N., Feng Y., Zhu M., Tsang C. M., Man K., Tong Y., Tsao S. W., Berberine induces autophagic cell death and mitochondrial apoptosis in liver cancer cells: the cellular mechanism. Journal of Cellular Biochemistry 2010 111 6 1426 1436 2-s2.0-78649775152 10.1002/jcb.22869
18. Chang K. S. S., Gao C., Wang L. C., Berberine-induced morphologic differentiation and down-regulation of c-Ki-ras2 protooncogene expression in human teratocarcinoma cells. Cancer Letters 1990 55 2 103 108 2-s2.0-0025600993 10.1016/0304-3835(90)90018-S
19. Tang F., Wang D., Duan C., Huang D., Wu Y., Chen Y., Wang W., Xie C., Meng J., Wang L., Wu B., Liu S., Tian D., Zhu F., He Z., Deng F., Cao Y., Berberine inhibits metastasis of nasopharyngeal carcinoma 5-8F cells by targeting rho kinase-mediated ezrin phosphorylation at threonine 567. Journal of Biological Chemistry 2009 284 40 27456 27466 2-s2.0-70350459062 10.1074/jbc.M109.033795
20. Ho Y. T., Yang J. S., Li T. C., Lin J. J., Lin J. G., Lai K. C., Ma C. Y., Wood W. G., Chung J. G., Berberine suppresses in vitro migration and invasion of human SCC-4 tongue squamous cancer cells through the inhibitions of FAK, IKK, NF- κ B, u-PA and MMP-2 and -9. Cancer Letters 2009 279 2 155 162 2-s2.0-67349103384 10.1016/j.canlet.2009.01.033
21. Jie S., Li H., Tian Y., Guo D., Zhu J., Gao S., Jiang L., Berberine inhibits angiogenic potential of Hep G2 cell line through VEGF down-regulation in vitro. Journal of Gastroenterology and Hepatology 2011 26 1 179 185 2-s2.0-78650400672 10.1111/j.1440-1746.2010.06389.x
22. Hamsa T. P., Kuttan G., Antiangiogenic activity of berberine is mediated through the downregulation of hypoxia-inducible factor-1, VEGF, and proinflammatory mediators. Drug and Chemical Toxicology 2012 35 1 57 70
23. Youn M. J., So H. S., Cho H. J., Kim H. J., Kim Y., Lee J. H., Sohn J. S., Kim Y. K., Chung S. Y., Park R., Berberine, a natural product, combined with cisplatin enhanced apoptosis through a mitochondria/caspase-mediated pathway in HeLa cells. Biological and Pharmaceutical Bulletin 2008 31 5 789 795 2-s2.0-44349121204 10.1248/bpb.31.789 (Pubitemid 351731963)
24. Hur J. M., Hyun M. S., Lim S. Y., Lee W. Y., Kim D., The combination of berberine and irradiation enhances anti-cancer effects via activation of p38 MAPK pathway and ROS generation in human hepatoma cells. Journal of Cellular Biochemistry 2009 107 5 955 964 2-s2.0-67749133572 10.1002/jcb.22198
25. Manoharan S., Sindhu G., Vinothkumar V., Berberine prevents 7,12-dimethylbenz[a]anthracene-induced hamster buccal pouch carcinogenesis: a biochemical approach. European Journal of Cancer Prevention 2012 21 2 182 192
26. Li X. L., Hu Y. J., Wang H., Molecular spectroscopy evidence for berberine binding to DNA: comparative binding and thermodynamic profile of intercalation. Biomacromolecules 2012 13 3 873 880
27. Islam M. M., Suresh Kumar G., RNA-binding potential of protoberberine alkaloids: spectroscopic and calorimetric studies on the binding of berberine, palmatine, and coralyne to protonated RNA structures. DNA and Cell Biology 2009 28 12 637 650 2-s2.0-72649086364 10.1089/dna.2009.0930
28. Mantena S. K., Sharma S. D., Katiyar S. K., Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Molecular Cancer Therapeutics 2006 5 2 296 308 2-s2.0-33644984254 10.1158/1535-7163.MCT-05-0448
29. Hamsa T. P., Kuttan G., Berberine inhibits pulmonary metastasis through down-regulation of MMP in metastatic B16F-10 melanoma cells. Phytotherapy Research 2011 26 4 568 578
30. Singh T., Vaid M., Katiyar N., Sharma S., Katiyar S. K., Berberine, an isoquinoline alkaloid, inhibits melanoma cancer cell migration by reducing the expressions of cyclooxygenase-2, prostaglandin E and prostaglandin E receptors. Carcinogenesis 2011 32 1 86 92 2-s2.0-79952198976
31. Kobayashi Y., Nakano Y., Kizaki M., Hoshikuma K., Yokoo Y., Kamiya T., Capsaicin-like anti-obese activities of evodiamine from fruits of Evodia rutaecarpa, a vanilloid receptor agonist. Planta Medica 2001 67 7 628 633 2-s2.0-0034815843 10.1055/s-2001-17353 (Pubitemid 32929573)
32. Kobayashi Y., The nociceptive and anti-nociceptive effects of evodiamine from fruits of Evodia rutaecarpa in mice. Planta Medica 2003 69 5 425 428 2-s2.0-0038434288 10.1055/s-2003-39701 (Pubitemid 36774182)
33. Shin Y. W., Bae E. A., Cai X. F., Lee J. J., Kim D. H., In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents. Biological and Pharmaceutical Bulletin 2007 30 1 197 199 2-s2.0-33846095017 10.1248/bpb.30.197 (Pubitemid 46066347)
34. Ko H. C., Wang Y. H., Liou K. T., Chen C. M., Chen C. H., Wang W. Y., Chang S., Hou Y. C., Chen K. T., Chen C. F., Shen Y. C., Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. European Journal of Pharmacology 2007 555 2-3 211 217 2-s2.0-33846031082 10.1016/j.ejphar.2006.10. 002 (Pubitemid 46048800)
35. Ogasawara M., Matsubara T., Suzuki H., Inhibitory effects of evodiamine on in vitro invasion and experimental lung metastasis of murine colon cancer cells. Biological and Pharmaceutical Bulletin 2001 24 8 917 920 2-s2.0-0034870541 10.1248/bpb.24.917 (Pubitemid 32750318)
36. Ogasawara M., Matsunaga T., Takahashi S., Saiki I., Suzuki H., Anti-invasive and metastatic activities of evodiamine. Biological and Pharmaceutical Bulletin 2002 25 11 1491 1493 2-s2.0-0242275764 10.1248/bpb.25.1491 (Pubitemid 39663174)
37. Fei X. F., Wang B. X., Li T. J., Tashiro S. I., Minami M., Xing D. J., Ikejima T., Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Science 2003 94 1 92 98 2-s2.0-0037986592 10.1111/j.1349-7006.2003.tb01358.x (Pubitemid 36575865)
38. Zhang Y., Wu L. J., Tashiro S. I., Onodera S., Ikejima T., Intracellular regulation of evodiamine-induced A375-S2 cell death. Biological and Pharmaceutical Bulletin 2003 26 11 1543 1547 2-s2.0-18244368114 10.1248/bpb.26.1543 (Pubitemid 41699632)
39. Shyu K. G., Lin S., Lee C. C., Chen E., Lin L. C., Wang B. W., Tsai S. C., Evodiamine inhibits in vitro angiogenesis: implication for antitumorgenicity. Life Sciences 2006 78 19 2234 2243 2-s2.0-33645223907 10.1016/j.lfs.2005.09.027
40. Lee T. J., Kim E. J., Kim S., Jung E. M., Park J. W., Jeong S. H., Park S. E., Yoo Y. H., Kwon T. K., Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Molecular Cancer Therapeutics 2006 5 9 2398 2407 2-s2.0-33749550856 10.1158/1535-7163.MCT-06-0167 (Pubitemid 44530477)
41. Wang C., Li S., Wang M. W., Evodiamine-induced human melanoma A375-S2 cell death was mediated by PI3K/Akt/caspase and Fas-L/NF- κ B signaling pathways and augmented by ubiquitin-proteasome inhibition. Toxicology in Vitro 2010 24 3 898 904 2-s2.0-77649178970 10.1016/j.tiv.2009.11.019
42. Yang J., Wu L. J., Tashino S. I., Onodera S., Ikejima T., Reactive oxygen species and nitric oxide regulate mitochondriadependent apoptosis and autophagy in evodiamine-treated human cervix carcinoma HeLa cells. Free Radical Research 2008 42 5 492 504 2-s2.0-46649120102 10.1080/10715760802112791 (Pubitemid 351935163)
43. Zhang Y., Zhang Q. H., Wu L. J., Tashiro S. I., Onodera S., Ikejima T., Atypical apoptosis in L929 cells induced by evodiamine isolated from Evodia rutaecarpa. Journal of Asian Natural Products Research 2004 6 1 19 27 2-s2.0-0442278366 10.1080/1028602031000119772 (Pubitemid 38190218)
44. Liao C. H., Pan S. L., Guh J. H., Chang Y. L., Pai H. C., Lin C. H., Teng C. M., Antitumor mechanism of evodiamine, a constituent from Chinese herb Evodiae fructus, in human multiple-drug resistant breast cancer NCI/ADR-RES cells in vitro and in vivo. Carcinogenesis 2005 26 5 968 975 2-s2.0-19844377252 10.1093/carcin/bgi041 (Pubitemid 41214326)
45. Tsai H. P., Lin L. W., Lai Z. Y., Wu J. Y., Chen C. E., Hwang J., Chen C. S., Lin C. M., Immobilizing topoisomerase I on a surface plasmon resonance biosensor chip to screen for inhibitors. Journal of Biomedical Science 2010 17 1, article 49 2-s2.0-77953594003 10.1186/1423-0127-17-49
46. Chan A. L. F., Chang W. S., Chen L. M., Lee C. M., Chen C. E., Lin C. M., Hwang J. L., Evodiamine stabilizes topoisomerase I-DNA cleavable complex to inhibit topoisomerase I activity. Molecules 2009 14 4 1342 1352 2-s2.0-66349130754 10.3390/molecules14041342
47. Dong G., Sheng C., Wang S., Miao Z., Yao J., Zhang W., Selection of evodiamine as a novel topoisomerase i inhibitor by structure-based virtual screening and hit optimization of evodiamine derivatives as antitumor agents. Journal of Medicinal Chemistry 2010 53 21 7521 7531 2-s2.0-78149253942 10.1021/jm100387d
48. Kan S. F., Huang W. J., Lin L. C., Wang P. S., Inhibitory effects of evodiamine on the growth of human prostate cancer cell line LNCaP. International Journal of Cancer 2004 110 5 641 651 2-s2.0-2942554803 10.1002/ijc.20138 (Pubitemid 38746021)
49. Huang Y. C., Guh J. H., Teng C. M., Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sciences 2004 75 1 35 49 2-s2.0-10344263866 10.1016/j.lfs.2003.11.025 (Pubitemid 38501763)
50. Yang J., Wu L. J., Tashino S. I., Onodera S., Ikejima T., Critical roles of reactive oxygen species in mitochondrial permeability transition in mediating evodiamine-induced human melanoma A375-S2 cell apoptosis. Free Radical Research 2007 41 10 1099 1108 2-s2.0-34748824207 10.1080/10715760701499356 (Pubitemid 47470847)
51. Lai J. P., He X. W., Jiang Y., Chen F., Preparative separation and determination of matrine from the Chinese medicinal plant Sophora flavescens Ait by molecularly imprinted solid-phase extraction. Analytical and Bioanalytical Chemistry 2003 375 2 264 269 2-s2.0-0037264313 10.1007/s00216-002-1675-2 (Pubitemid 41201303)
52. Li X., Zhou R., Zheng P., Yan L., Wu Y., Xiao X., Dai G., Cardioprotective effect of matrine on isoproterenol-induced cardiotoxicity in rats. Journal of Pharmacy and Pharmacology 2010 62 4 514 520 2-s2.0-77952870009 10.1211/jpp/62.04.0015
53. Xing Y., Yan F., Liu Y., Liu Y., Zhao Y., Matrine inhibits 3T3-L1 preadipocyte differentiation associated with suppression of ERK1/2 phosphorylation. Biochemical and Biophysical Research Communications 2010 396 3 691 695 2-s2.0-77953027498 10.1016/j.bbrc.2010.04.163
54. Zheng J., Zheng P., Zhou X., Yan L., Zhou R., Fu X. Y., Dai G. D., Relaxant effects of matrine on aortic smooth muscles of guinea pigs. Biomedical and Environmental Sciences 2009 22 4 327 332 2-s2.0-70350509580 10.1016/S0895-3988(09)60063-5
55. Long Y., Lin X. T., Zeng K. L., Zhang L., Efficacy of intramuscular matrine in the treatment of chronic hepatitis B. Hepatobiliary and Pancreatic Diseases International 2004 3 1 69 72 2-s2.0-1342287277 (Pubitemid 38256128)
56. Zhang B., Liu Z. Y., Li Y. Y., Antiinflammatory effects of matrine in LPS-induced acute lung injury in mice. European Journal of Pharmaceutical Sciences 2011 44 5 573 579
57. Han Y., Zhang S., Wu J., Yu K., Yu Z., Yin L., Bi L., Matrine induces apoptosis of human multiple myeloma cells via activation of the mitochondrial pathway. Leukemia and Lymphoma 2010 51 7 1337 1346 2-s2.0-77954101125 10.3109/10428194.2010.488708
58. Zhang L., Wang T., Wen X., Wei Y., Peng X., Li H., Wei L., Effect of matrine on HeLa cell adhesion and migration. European Journal of Pharmacology 2007 563 13 69 76 2-s2.0-34247128303 10.1016/j.ejphar.2007.01.073 (Pubitemid 46602230)
59. Dai Z. J., Gao J., Ji Z. Z., Wang X. J., Ren H. T., Liu X. X., Wu W. Y., Kang H. F., Guan H. T., Matrine induces apoptosis in gastric carcinoma cells via alteration of Fas/FasL and activation of caspase-3. Journal of Ethnopharmacology 2009 123 1 91 96 2-s2.0-64249154146 10.1016/j.jep.2009.02.022
60. Liu T., Song Y., Chen H., Pan S., Sun X., Matrine inhibits proliferation and induces apoptosis of pancreatic cancer cells in vitro and in vivo. Biological and Pharmaceutical Bulletin 2010 33 10 1740 1745 2-s2.0-77957987817
61. Liang C. Z., Zhang J. K., Shi Z., Liu B., Shen C. Q., Tao H. M., Matrine induces caspase-dependent apoptosis in human osteosarcoma cells in vitro and in vivo through the upregulation of Bax and Fas/FasL and downregulation of Bcl-2. Cancer Chemotherapy and Pharmacology 2011 69 2 317 331 2-s2.0-79959617391 10.1007/s00280-011-1699-4
62. Zhang P., Wang Z., Chong T., Matrine inhibits proliferation and induces apoptosis of the androgenindependent prostate cancer cell line PC-3. Molecular Medicine Reports 2012 5 3 783 787
63. Zhang Z., Wang X., Wu W., Effects of matrine on proliferation and apoptosis in gallbladder carcinoma cells (GBC-SD). Phytotherapy research 2011 26 6 932 937
64. Jiang H., Hou C., Zhang S., Xie H., Zhou W., Jin Q., Cheng X., Qian R., Zhang X., Matrine upregulates the cell cycle protein E2F-1 and triggers apoptosis via the mitochondrial pathway in K562 cells. European Journal of Pharmacology 2007 559 2-3 98 108 2-s2.0-33847136330 10.1016/j.ejphar.2006.12.017 (Pubitemid 46295409)
65. Zhang J. Q., Li Y. M., Liu T., He W. T., Chen Y. T., Chen X. H., Li X., Zhou W. C., Yi J. F., Ren Z. J., Antitumor effect of matrine in human hepatoma G2 cells by inducing apoptosis and autophagy. World Journal of Gastroenterology 2010 16 34 4281 4290 2-s2.0-77957557122 10.3748/wjg.v16.i34.4281
66. Zhang J., Li Y., Chen X., Liu T., Chen Y., He W., Zhang Q., Liu S., Autophagy is involved in anticancer effects of matrine on SGC-7901 human gastric cancer cells. Oncology Reports 2011 26 1 115 124 2-s2.0-79955838925 10.3892/or.2011.1277
67. Zhang L. P., Jiang J. K., Tam J. W. O., Zhang Y., Liu X. S., Xu X. R., Liu B. Z., He Y. J., Effects of Matrine on proliferation and differentiation in K-562 cells. Leukemia Research 2001 25 9 793 800 2-s2.0-0034900502 10.1016/S0145-2126(00)00145-4 (Pubitemid 32734092)
68. Li H., Tan G., Jiang X., Qiao H., Pan S., Jiang H., Kanwar J. R., Sun X., Therapeutic effects of matrine on primary and metastatic breast cancer. American Journal of Chinese Medicine 2010 38 6 1115 1130 2-s2.0-78149434361 10.1142/S0192415X10008512
69. Ma L., Wen S., Zhan Y., He Y., Liu X., Jiang J., Anticancer effects of the Chinese medicine matrine on murine hepatocellular carcinoma cells. Planta Medica 2008 74 3 245 251 2-s2.0-41349091860 10.1055/s-2008-1034304 (Pubitemid 351449946)
70. Zhang W., Dai B. T., Xu Y. H., Effects of matrine on invasion and metastasis of leukemia cell line Jurkat. Zhongguo Zhong xi yi jie he za zhi 2008 28 10 907 911 2-s2.0-77955499792
71. Yu P., Liu Q., Liu K., Yagasaki K., Wu E., Zhang G., Matrine suppresses breast cancer cell proliferation and invasion via VEGF-Akt-NF- κ B signaling. Cytotechnology 2009 59 3 219 229 2-s2.0-70449534614 10.1007/s10616-009-9225-9
72. Yu H. B., Zhang H. F., Li D. Y., Zhang X., Xue H. Z., Zhao S. H., Matrine inhibits matrix metalloproteinase-9 expression and invasion of human hepatocellular carcinoma cells. Journal of Asian Natural Products Research 2011 13 3 242 250 2-s2.0-79952780900 10.1080/10286020.2010.551641
73. Luo C., Zhong H. J., Zhu L. M., Inhibition of matrine against gastric cancer cell line MNK45 growth and its anti-tumor mechanism. Molecular Biology Reports 2011 39 5 5459 5464
74. Szallasi A., Piperine: researchers discover new flavor in an ancient spice. Trends in Pharmacological Sciences 2005 26 9 437 439 2-s2.0-23944472482 10.1016/j.tips.2005.07.001 (Pubitemid 41207873)
75. Srinivasan K., Black pepper and its pungent principle-piperine: a review of diverse physiological effects. Critical Reviews in Food Science and Nutrition 2007 47 8 735 748 2-s2.0-35948951161 10.1080/10408390601062054 (Pubitemid 350072517)
76. Bae G. S., Kim M. S., Jung W. S., Seo S. W., Yun S. W., Kim S. G., Park R. K., Kim E. C., Song H. J., Park S. J., Inhibition of lipopolysaccharide- induced inflammatory responses by piperine. European Journal of Pharmacology 2010 642 13 154 162 2-s2.0-77954623788 10.1016/j.ejphar.2010.05.026
77. Lee S. A., Hong S. S., Han X. H., Hwang J. S., Oh G. J., Lee K. S., Lee M. K., Hwang B. Y., Ro J. S., Piperine from the fruits of Piper longum with inhibitory effect on monoamine oxidase and antidepressant-like activity. Chemical and Pharmaceutical Bulletin 2005 53 7 832 835 2-s2.0-24944476938 10.1248/cpb.53.832 (Pubitemid 41327633)
78. Li S., Wang C., Wang M., Li W., Matsumoto K., Tang Y., Antidepressant like effects of piperine in chronic mild stress treated mice and its possible mechanisms. Life Sciences 2007 80 15 1373 1381 2-s2.0-33847624059 10.1016/j.lfs.2006.12.027 (Pubitemid 46367065)
79. Krishnakumar N., Manoharan S., Palaniappan P. R., Venkatachalam P., Manohar M. G. A., Chemopreventive efficacy of piperine in 7,12-dimethyl benz [a] anthracene (DMBA)-induced hamster buccal pouch carcinogenesis: an FT-IR study. Food and Chemical Toxicology 2009 47 11 2813 2820 2-s2.0-70350203964 10.1016/j.fct.2009.08.017
80. Selvendiran K., Banu S. M., Sakthisekaran D., Oral supplementation of piperine leads to altered phase II enzymes and reduced DNA damage and DNA-protein cross links in Benzo(a)pyrene induced experimental lung carcinogenesis. Molecular and Cellular Biochemistry 2005 268 1-2 141 147 2-s2.0-14244265798 10.1007/s11010-005-3702-z (Pubitemid 40287836)
81. Selvendiran K., Sakthisekaran D., Chemopreventive effect of piperine on modulating lipid peroxidation and membrane bound enzymes in benzo(a)pyrene induced lung carcinogenesis. Biomedicine and Pharmacotherapy 2004 58 4 264 267 2-s2.0-2942529470 10.1016/j.biopha.2003.08.027 (Pubitemid 38746755)
82. Selvendiran K., Thirunavukkarasu C., Singh J. P. V., Padmavathi R., Sakthisekaran D., Chemopreventive effect of piperine on mitochondrial TCA cycle and phase-I and glutathione-metabolizing enzymes in benzo(a)pyrene induced lung carcinogenesis in Swiss albino mice. Molecular and Cellular Biochemistry 2005 271 1-2 101 106 2-s2.0-17244367032 10.1007/s11010-005-5615-2 (Pubitemid 40528467)
83. Selvendiran K., Singh J. P. V., Krishnan K. B., Sakthisekaran D., Cytoprotective effect of piperine against benzo[a]pyrene induced lung cancer with reference to lipid peroxidation and antioxidant system in Swiss albino mice. Fitoterapia 2003 74 1-2 109 115 2-s2.0-0037291836 10.1016/S0367-326X(02) 00304-0 (Pubitemid 36287253)
84. Khajuria A., Thusu N., Zutshi U., Bedi K. L., Piperine modulation of carcinogen induced oxidative stress in intestinal mucosa. Molecular and Cellular Biochemistry 1998 189 1-2 113 118 2-s2.0-0031732661 (Pubitemid 28556555)
85. Manoharan S., Balakrishnan S., Menon V. P., Alias L. M., Reena A. R., Chemopreventive & efficacy of curcumin and piperine during 7,12-dimethylbenz [a]anthracene-induced hamster buccal pouch carcinogenesis. Singapore Medical Journal 2009 50 2 139 146 2-s2.0-63449108915
86. Bezerra D. P., Castro F. O., Alves A. P. N. N., Pessoa C., Moraes M. O., Silveira E. R., Lima M. A. S., Elmiro F. J. M., Costa-Lotufo L. V., In vivo growth-inhibition of Sarcoma 180 by piplartine and piperine, two alkaloid amides from piper. Brazilian Journal of Medical and Biological Research 2006 39 6 801 807 2-s2.0-33745106915 10.1590/S0100-879X2006000600014 (Pubitemid 43880939)
87. Kakarala M., Brenner D. E., Korkaya H., Cheng C., Tazi K., Ginestier C., Liu S., Dontu G., Wicha M. S., Targeting breast stem cells with the cancer preventive compounds curcumin and piperine. Breast Cancer Research and Treatment 2010 122 3 777 785 2-s2.0-77955559259 10.1007/s10549-009-0612-x
88. Lai L. H., Fu Q. H., Liu Y., Piperine suppresses tumor growth and metastasis in vitro and in vivo in a 4T1 murine breast cancer model. Acta Pharmacologica Sinica 2012 33 4 523 530
89. Song Q. F., Qu Y. C., Zheng H. B., Zhang G. H., Lin H. G., Yang J. L., Differentiation of erythroleukemia K562 cells induced by piperine. Ai Zheng 2008 27 6 571 574 2-s2.0-77953632661
90. Pradeep C. R., Kuttan G., Effect of piperine on the inhibition of lung metastasis induced B16F-10 melanoma cells in mice. Clinical and Experimental Metastasis 2002 19 8 703 708 2-s2.0-0036939104 10.1023/A:1021398601388 (Pubitemid 36092266)
91. Hwang Y. P., Yun H. J., Kim H. G., Han E. H., Choi J. H., Chung Y. C., Jeong H. G., Suppression of phorbol-12-myristate-13-acetate-induced tumor cell invasion by piperine via the inhibition of PKC α /ERK1/2-dependent matrix metalloproteinase-9 expression. Toxicology Letters 2011 203 1 9 19 2-s2.0-79954645941 10.1016/j.toxlet.2011.02.013
92. Pradeep C. R., Kuttan G., Piperine is a potent inhibitor of nuclear factor- κ B (NF- κ B), c-Fos, CREB, ATF-2 and proinflammatory cytokine gene expression in B16F-10 melanoma cells. International Immunopharmacology 2004 4 14 1795 1803 2-s2.0-8644238077 10.1016/j.intimp.2004. 08.005 (Pubitemid 39504820)
93. Bhardwaj R. K., Glaeser H., Becquemont L., Klotz U., Gupta S. K., Fromm M. F., Piperine, a major constituent of black pepper, inhibits human P-glycoprotein and CYP3A4. Journal of Pharmacology and Experimental Therapeutics 2002 302 2 645 650 2-s2.0-0036070626 10.1124/jpet.102.034728 (Pubitemid 34787231)
94. Li S., Lei Y., Jia Y., Li N., Wink M., Ma Y., Piperine, a piperidine alkaloid from Piper nigrum re-sensitizes P-gp, MRP1 and BCRP dependent multidrug resistant cancer cells. Phytomedicine 2011 19 1 83 87 2-s2.0-79960665045 10.1016/j.phymed.2011.06.031
95. Makhov P., Golovine K., Canter D., Kutikov A., Simhan J., Corlew M. M., Uzzo R. G., Kolenko V. M., Co-administration of piperine and docetaxel results in improved anti-tumor efficacy via inhibition of CYP3A4 activity. Prostate 2011 72 6 661 667 2-s2.0-79960694737 10.1002/pros.21469
96. Mahady G. B., Beecher C. W. W., Quercetin-induced benzophenanthridine alkaloid production in suspension cell cultures of Sanguinaria canadensis. Planta Medica 1994 60 6 553 557 2-s2.0-0028102893 10.1055/s-2006-959570 (Pubitemid 24382567)
97. Vavrečková C., Gawlik I., Müller K., Benzophenanthridine alkaloids of Chelidonium majus; I. Inhibition of 5- and 12-lipoxygenase by a non-redox mechanism. Planta Medica 1996 62 5 397 401 2-s2.0-0029829338 10.1055/s-2006-957924 (Pubitemid 26370327)
98. Lenfeld J., Kroutil M., Marsalek E., Antiinflammatory activity of quaternary benzophenanthridine alkaloids from Chelidonium majus. Planta Medica 1981 43 2 161 165 2-s2.0-0019787435 (Pubitemid 12206675)
99. Beuria T. K., Santra M. K., Panda D., Sanguinarine blocks cytokinesis in bacteria by inhibiting FtsZ assembly a bundling. Biochemistry 2005 44 50 16584 16593 2-s2.0-29244432515 10.1021/bi050767+ (Pubitemid 41832040)
100. Jeng J. H., Wu H. L., Lin B. R., Lan W. H., Chang H. H., Ho Y. S., Lee P. H., Wang Y. J., Wang J. S., Chen Y. J., Chang M. C., Antiplatelet effect of sanguinarine is correlated to calcium mobilization, thromboxane and cAMP production. Atherosclerosis 2007 191 2 250 258 2-s2.0-33947198685 10.1016/j.atherosclerosis.2006.05.023 (Pubitemid 46420443)
101. Ahsan H., Reagan-Shaw S., Breur J., Ahmad N., Sanguinarine induces apoptosis of human pancreatic carcinoma AsPC-1 and BxPC-3 cells via modulations in Bcl-2 family proteins. Cancer Letters 2007 249 2 198 208 2-s2.0-33947402249 10.1016/j.canlet.2006.08.018 (Pubitemid 46452928)
102. Chang M. C., Chan C. P., Wang Y. J., Lee P. H., Chen L. I., Tsai Y. L., Lin B. R., Wang Y. L., Jeng J. H., Induction of necrosis and apoptosis to KB cancer cells by sanguinarine is associated with reactive oxygen species production and mitochondrial membrane depolarization. Toxicology and Applied Pharmacology 2007 218 2 143 151 2-s2.0-33846626446 10.1016/j.taap.2006.10.025 (Pubitemid 46177167)
103. Debiton E., Madelmont J. C., Legault J., Barthomeuf C., Sanguinarine-induced apoptosis is associated with an early and severe cellular glutathione depletion. Cancer Chemotherapy and Pharmacology 2003 51 6 474 482 2-s2.0-0037713603 (Pubitemid 36791672)
104. Hussain A. R., Al-Jomah N. A., Siraj A. K., Manogaran P., Al-Hussein K., Abubaker J., Platanias L. C., Al-Kuraya K. S., Uddin S., Sanguinarine-dependent induction of apoptosis in primary effusion lymphoma cells. Cancer Research 2007 67 8 3888 3897 2-s2.0-34248582774 10.1158/0008-5472.CAN-06-3764 (Pubitemid 46762177)
105. Kim S., Lee T. J., Leem J., Kyeong S. C., Park J. W., Taeg K. K., Sanguinarine-induced apoptosis: generation of ROS, down-regulation of Bcl-2, c-FLIP, and synergy with TRAIL. Journal of Cellular Biochemistry 2008 104 3 895 907 2-s2.0-45149130752 10.1002/jcb.21672 (Pubitemid 351830838)
106. Adhami V. M., Aziz M. H., Mukhtar H., Ahmad N., Activation of prodeath Bcl-2 family proteins and mitochondrial apoptosis pathway by sanguinarine in immortalized human HaCaT keratinocytes. Clinical Cancer Research 2003 9 8 3176 3182 2-s2.0-0043026772 (Pubitemid 36993280)
107. Adhami V. M., Aziz M. H., Reagan-Shaw S. R., Nihal M., Mukhtar H., Ahmad N., Sanguinarine causes cell cyle blockade and apoptosis of human prostate carcinoma cells via modulation of cylin kinase inhibitor-cyclin-cyclin-dependent kinase machinery. Molecular Cancer Therapeutics 2004 3 8 933 940 2-s2.0-4444220152 (Pubitemid 39199588)
108. Weerasinghe P., Hallock S., Tang S. C., Trump B., Liepins A., Sanguinarine overcomes P-glycoprotein-mediated multidrug-resistance via induction of apoptosis and oncosis in CEM-VLB 1000 cells. Experimental and Toxicologic Pathology 2006 58 1 21 30 2-s2.0-33746374708 10.1016/j.etp.2006.01. 008 (Pubitemid 44109782)
109. De Stefano I., Raspaglio G., Zannoni G. F., Travaglia D., Prisco M. G., Mosca M., Ferlini C., Scambia G., Gallo D., Antiproliferative and antiangiogenic effects of the benzophenanthridine alkaloid sanguinarine in melanoma. Biochemical Pharmacology 2009 78 11 1374 1381 2-s2.0-70349781670 10.1016/j.bcp.2009.07.011
110. Choi Y. H., Choi W. Y., Hong S. H., Kim S. O., Kim G. Y., Lee W. H., Yoo Y. H., Anti-invasive activity of sanguinarine through modulation of tight junctions and matrix metalloproteinase activities in MDA-MB-231 human breast carcinoma cells. Chemico-Biological Interactions 2009 179 2-3 185 191 2-s2.0-62549160369 10.1016/j.cbi.2008.11.009
111. Huh J., Liepins A., Zielonka J., Andrekopoulos C., Kalyanaraman B., Sorokin A., Cyclooxygenase 2 rescues LNCaP prostate cancer cells from sanguinarine-induced apoptosis by a mechanism involving inhibition of nitric oxide synthase activity. Cancer Research 2006 66 7 3726 3736 2-s2.0-33645734867 10.1158/0008-5472.CAN-05-4033
112. Ahsan H., Reagan-Shaw S., Eggert D. M., Tan T. C., Afaq F., Mukhtar H., Ahmad N., Protective effect of sanguinarine on ultraviolet B-mediated damages in SKH-1 hairless mouse skin: implications for prevention of skin cancer. Photochemistry and Photobiology 2007 83 4 986 993 2-s2.0-34447642659 10.1111/j.1751-1097.2007.00156.x (Pubitemid 47087401)
113. Jang B. C., Park J. G., Song D. K., Baek W. K., Yoo S. K., Jung K. H., Park G. Y., Lee T. Y., Suh S. I., Sanguinarine induces apoptosis in A549 human lung cancer cells primarily via cellular glutathione depletion. Toxicology in Vitro 2009 23 2 281 287 2-s2.0-59449083445 10.1016/j.tiv.2008.12.013
114. 2 generation and topoisomerase II inhibition. Free Radical Biology and Medicine 2008 45 5 627 635 2-s2.0-48449089245 10.1016/j.freeradbiomed.2008.05.017
115. Cai Y., Lu J., Miao Z., Lin L., Ding J., Reactive oxygen species contribute to cell killing and P-glycoprotein downregulation by salvicine in multidrug resistant K562/A02 cells. Cancer Biology and Therapy 2007 6 11 1794 1799 2-s2.0-42549144022 (Pubitemid 351590315)
116. Vogt A., Tamewitz A., Skoko J., Sikorski R. P., Giuliano K. A., Lazo J. S., The benzo[c]phenanthridine alkaloid, sanguinarine, is a selective, cell-active inhibitor of mitogen-activated protein kinase phosphatase-1. Journal of Biological Chemistry 2005 280 19 19078 19086 2-s2.0-21344451886 10.1074/jbc.M501467200 (Pubitemid 41379614)
117. Lopus M., Panda D., The benzophenanthridine alkaloid sanguinarine perturbs microtubule assembly dynamics through tubulin binding: a possible mechanism for its antiproliferative activity. FEBS Journal 2006 273 10 2139 2150 2-s2.0-33646241080 10.1111/j.1742-4658.2006.05227.x
118. Holy J., Lamont G., Perkins E., Disruption of nucleocytoplasmic trafficking of cylin DI and topoisomerase II by sanguinarine. BMC Cell Biology 2006 7, article 13 2-s2.0-33645840140 10.1186/1471-2121-7-13
119. Chaturvedi M. M., Kumar A., Darnay B. G., Chainy G. B. N., Agarwal S., Aggarwal B. B., Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF- κ B activation, I κ B α phosphorylation, and degradation. Journal of Biological Chemistry 1997 272 48 30129 30134 2-s2.0-0030773543 10.1074/jbc.272.48.30129 (Pubitemid 27512211)
120. Sun M., Liu C., Nadiminty N., Lou W., Zhu Y., Yang J., Evans C. P., Zhou Q., Gao A. C., Inhibition of Stat3 activation by sanguinarine suppresses prostate cancer cell growth and invasion. Prostate 2011 72 1 82 89 2-s2.0-79955382740 10.1002/pros.21409
121. Li D. G., Wang Z. R., Lu H. M., Pharmacology of tetrandrine and its therapeutic use in digestive diseases. World Journal of Gastroenterology 2001 7 5 627 629 2-s2.0-0034777143
122. Ng L. T., Chiang L. C., Lin Y. T., Lin C. C., Antiproliferative and apoptotic effects of tetrandrine on different human hepatoma cell lines. American Journal of Chinese Medicine 2006 34 1 125 135 2-s2.0-32544437231 10.1142/S0192415X06003692 (Pubitemid 43231407)
123. Kuo P. L., Lin C. C., Tetrandrine-induced cell cycle arrest and apoptosis in Hep G2 cells. Life Sciences 2003 73 2 243 252 2-s2.0-0038555818 10.1016/S0024-3205(03)00266-2 (Pubitemid 36559604)
124. Meng L. H., Zhang H., Hayward L., Takemura H., Shao R. G., Pommier Y., Tetrandrine induces early G1 arrest in human colon carcinoma cells by down-regulating the activity and inducing the degradation of G 1-S-specific cyclin-dependent kinases and by inducing p53 and p21Cip1. Cancer Research 2004 64 24 9086 9092 2-s2.0-10844230330 10.1158/0008-5472.CAN-04-0313 (Pubitemid 39665522)
125. Li X., Su B., Liu R., Wu D., He D., Tetrandrine induces apoptosis and triggers caspase cascade in human bladder cancer cells. Journal of Surgical Research 2011 166 1 e45 e51 2-s2.0-79951680794 10.1016/j.jss.2010.10.034
126. He B. C., Gao J. L., Zhang B. Q., Tetrandrine inhibits Wnt/beta-catenin signaling and suppresses tumor growth of human colorectal cancer. Molecular Pharmacology 2011 79 2 211 219
127. Wu J. M., Chen Y., Chen J. C., Lin T. Y., Tseng S. H., Tetrandrine induces apoptosis and growth suppression of colon cancer cells in mice. Cancer Letters 2010 287 2 187 195 2-s2.0-72949109102 10.1016/j.canlet.2009.06.009
128. Yoo S. M., Oh S. H., Lee S. J., Lee B. W., Ko W. G., Moon C. K., Lee B. H., Inhibition of proliferation and induction of apoptosis by tetrandrine in HepG2 cells. Journal of Ethnopharmacology 2002 81 2 225 229 2-s2.0-0036281314 10.1016/S0378-8741(02)00082-X (Pubitemid 34628506)
129. Lee J. H., Kang G. H., Kim K. C., Kim K. M., Park D. I., Choi B. T., Kang H. S., Lee Y. T., Choi Y. H., Tetrandrine-induced cell cycle arrest and apoptosis in A549 human lung carcinoma cells. International Journal of Oncology 2002 21 6 1239 1244 2-s2.0-0042253200
130. Lai Y. L., Chen Y. J., Wu T. Y., Wang S. Y., Chang K. H., Chung C. H., Chen M. L., Induction of apoptosis in human leukemic U937 cells by tetrandrine. Anti-Cancer Drugs 1998 9 1 77 81 2-s2.0-0031886289 10.1097/00001813-199801000- 00009 (Pubitemid 28088182)
131. Chen Y., Chen J. C., Tseng S. H., Tetrandrine suppresses tumor growth and angiogenesis of gliomas in rats. International Journal of Cancer 2009 124 10 2260 2269 2-s2.0-64249171902 10.1002/ijc.24208
132. Chang K. H., Liao H. F., Chang H. H., Chen Y. Y., Yu M. C., Chou C. J., Chen Y. J., Inhibitory effect of tetrandrine on pulmonary metastases in CT26 colorectal adenocarcinoma-bearing BALB/c mice. American Journal of Chinese Medicine 2004 32 6 863 872 2-s2.0-10944234973 10.1142/S0192415X04002478 (Pubitemid 40012455)
133. Fu L. W., Zhang Y. M., Liang Y. J., Yang X. P., Pan Q. C., The multidrug resistance of tumour cells was reversed by tetrandrine in vitro and in xenografts derived from human breast adenocarcinoma MCF-7/adr cells. European Journal of Cancer 2002 38 3 418 426 2-s2.0-0036164671 10.1016/S0959-8049(01) 00356-2 (Pubitemid 34121971)
134. Zhu X., Sui M., Fan W., In vitro and in vivo characterizations of tetrandrine on the reversal of P-glycoprotein-mediated drug resistance to paclitaxel. Anticancer Research 2005 25 3 1953 1962 2-s2.0-21344445915 (Pubitemid 40904590)
135. Fu L., Liang Y., Deng L., Ding Y., Chen L., Ye Y., Yang X., Pan Q., Characterization of tetrandrine, a potent inhibitor of P-glycoprotein-mediated multidrug resistance. Cancer Chemotherapy and Pharmacology 2004 53 4 349 356 2-s2.0-1642299307 10.1007/s00280-003-0742-5 (Pubitemid 38392360)
136. Zhang Y., Wang C., Wang H., Wang K., Du Y., Zhang J., Combination of Tetrandrine with cisplatin enhances cytotoxicity through growth suppression and apoptosis in ovarian cancer in vitro and in vivo. Cancer Letters 2011 304 1 21 32 2-s2.0-79952251376 10.1016/j.canlet.2011.01.022
137. Wei J., Liu B., Wang L., Qian X., Ding Y., Yu L., Synergistic interaction between tetrandrine and chemotherapeutic agents and influence of tetrandrine on chemotherapeutic agent-associated genes in human gastric cancer cell lines. Cancer Chemotherapy and Pharmacology 2007 60 5 703 711 2-s2.0-34547842366 10.1007/s00280-007-0416-9 (Pubitemid 47247282)
138. Iorns E., Lord C. J., Ashworth A., Parallel RNAi and compound screens identify the PDK1 pathway as a target for tamoxifen sensitization. Biochemical Journal 2009 417 1 361 370 2-s2.0-58249090328 10.1042/BJ20081682
139. Yu J., Liu F., Sun M., Enhancement of radiosensitivity and the potential mechanism on human esophageal carcinoma cells by tetrandrine. Cancer Biotherapy and Radiopharmaceuticals 2011 26 4 437 442
140. Chang K. H., Chen M. L., Chen H. C., Huang Y. W., Wu T. Y., Chen Y. J., Enhancement of radiosensitivity in human glioblastoma U138MG cells by tetrandrine. Neoplasma 1999 46 3 196 200 2-s2.0-0032786803 (Pubitemid 29398321)
141. Chen Y., Chen J. C., Tseng S. H., Effects of tetrandrine plus radiation on neuroblastoma cells. Anticancer Research 2009 29 8 3163 3171 2-s2.0-68549109512
142. Sun X. C., Cheng H. Y., Deng Y. X., Shao R. G., Ma J., Tetrandrine: a potent abrogator of G2 checkpoint function in tumor cells and its mechanism. Biomedical and Environmental Sciences 2007 20 6 495 501 2-s2.0-38949179119 (Pubitemid 351224814)
143. Sun X., Xu R., Deng Y., Cheng H., Ma J., Ji J., Zhou Y., Effects of tetrandrine on apoptosis and radiosensitivity of nasopharyngeal carcinoma cell line CNE. Acta Biochimica et Biophysica Sinica 2007 39 11 869 878 2-s2.0-36248959143 10.1111/j.1745-7270.2007.00349.x (Pubitemid 350136894)
144. McCubrey J. A., Bäsecke J., Cervello M., Martelli A. M., Franklin R. A., GSK-3 β is a critical mediator of tetrandrine induced cell cycle arrest and cytotoxicity. Cancer Biology and Therapy 2008 7 7 1079 2-s2.0-47949130709
145. Chen X. L., Ren K. H., He H. W., Involvement of PI3K/AKT/GSK3beta pathway in tetrandrine-induced G1 arrest and apoptosis. Cancer Biology and Therapy 2008 7 7 1073 1078
146. Liu C., Gong K., Mao X., Li W., Tetrandrine induces apoptosis by activating reactive oxygen species and repressing Akt activity in human hepatocellular carcinoma. International Journal of Cancer 2011 129 6 1519 1531 2-s2.0-79959757676 10.1002/ijc.25817
147. Oh S. H., Lee B. H., Induction of apoptosis in human hepatoblastoma cells by tetrandrine via caspase-dependent Bid cleavage and cytochrome c release. Biochemical Pharmacology 2003 66 5 725 731 2-s2.0-0041930586 10.1016/S0006-2952(03)00397-6 (Pubitemid 37011410)
148. Cho H. S., Chang S. H., Chung Y. S., Shin J. Y., Park S. J., Lee E. S., Hwang S. K., Kwon J. T., Tehrani A. M., Woo M., Noh M. S., Hanifah H., Jin H., Xu C. X., Cho M. H., Synergistic effect of ERK inhibition on tetrandrine-induced apoptosis in A549 human lung carcinoma cells. Journal of Veterinary Science 2009 10 1 23 28 2-s2.0-64849099003 10.4142/jvs.2009.10.1.23
149. Larsen A. K., Grondard L., Couprie J., Desoize B., Comoe L., Jardillier J. C., Riou J. F., The antileukemic alkaloid fagaronine is an inhibitor of DNA topoisomerases I and II. Biochemical Pharmacology 1993 46 8 1403 1412 2-s2.0-0027369170 10.1016/0006-2952(93)90105-6 (Pubitemid 23319310)
150. Lamoral-Theys D., Decaestecker C., Mathieu V., Dubois J., Kornienko A., Kiss R., Evidente A., Pottier L., Lycorine and its derivatives for anticancer drug design. Mini-Reviews in Medicinal Chemistry 2010 10 1 41 50 2-s2.0-77951143131 10.2174/138955710791112604
151. Chen J., Wang J., Lin L., Inhibition of STAT3 signaling pathway by nitidine chloride suppressed the angiogenesis and growth of human gastric cancer. Molecular Cancer Therapeutics 2011 11 2 277 287
152. Ji Y. B., Gao S. Y., Ji C. F., Zou X., Induction of apoptosis in HepG2 cells by solanine and Bcl-2 protein. Journal of Ethnopharmacology 2008 115 2 194 202 2-s2.0-37249089342 10.1016/j.jep.2007.09.023 (Pubitemid 350266263)
153. Li X. M., Li L. Z., Chen S. L., Inhibitory effects of sophocarpine on animal tumors. Acta Pharmacologica Sinica 1984 5 2 125 130 2-s2.0-0021254701 (Pubitemid 14120652)
154. Jiang J., Hu C., Evodiamine: a novel anti-cancer alkaloid from evodia rutaecarpa. Molecules 2009 14 5 1852 1859 2-s2.0-67249138744 10.3390/molecules14051852
155. Pei Y. Q., A review of pharmacology and clinical use of piperine and its derivatives. Epilepsia 1983 24 2 177 182 2-s2.0-0020537846 (Pubitemid 13122742)
156. Lahiri S. C., Dutta N. K., Berberine and chloramphenicol in the treatment of cholera and severe diarrhoea. Journal of the Indian Medical Association 1967 48 1 1 11 2-s2.0-0014043543
157. Bezerra D. P., De Castro F. O., Alves A. P. N. N., Pessoa C., De Moraes M. O., Silveira E. R., Lima M. A. S., Elmiro F. J. M., De Alencar N. M. N., Mesquita R. O., Lima M. W., Costa-Lotufo L. V., In vitro and in vivo antitumor effect of 5-FU combined with piplartine and piperine. Journal of Applied Toxicology 2008 28 2 156 163 2-s2.0-41149150829 10.1002/jat.1261 (Pubitemid 351428288)
158. Hu M. J., Zeng H., Wu Y. L., Zhang Y. P., Zhang S., Qiao M. M., Fu H., Synergistic effects of matrine and 5-fluorouracil on tumor growth of the implanted gastric cancer in nude mice. Chinese Journal of Digestive Diseases 2005 6 2 68 71 2-s2.0-21644475166 10.1111/j.1443-9573.2005.00201.x (Pubitemid 40936488)
159. Lu J. J., Pan W., Hu Y. J., Multi-target drugs: the trend of drug research and development. PLoS ONE 2012 7 6 e40262
160. Lu J. J., Cai Y. J., Ding J., Curcumin induces DNA damage and caffeine-insensitive cell cycle arrest in colorectal carcinoma HCT116 cells. Molecular and Cellular Biochemistry 2011 354 1-2 247 252 2-s2.0-79959801239 10.1007/s11010-011-0824-3
161. Lu J. J., Chen S. M., Zhang X. W., Ding J., Meng L. H., The anti-cancer activity of dihydroartemisinin is associated with induction of iron-dependent endoplasmic reticulum stress in colorectal carcinoma HCT116 cells. Investigational New Drugs 2011 29 6 1276 1283 2-s2.0-77954421704 10.1007/s10637-010-9481-8
162. Zhu H., Liu X. W., Ding W. J., Xu D. Q., Zhao Y. C., Lu W., He Q. J., Yang B., Up-regulation of death receptor 4 and 5 by celastrol enhances the anti-cancer activity of TRAIL/Apo-2L. Cancer Letters 2010 297 2 155 164 2-s2.0-77956407726 10.1016/j.canlet.2010.04.030
163. Lu J. J., Meng L. H., Shankavaram U. T., Zhu C. H., Tong L. J., Chen G., Lin L. P., Weinstein J. N., Ding J., Dihydroartemisinin accelerates c-MYC oncoprotein degradation and induces apoptosis in c-MYC-overexpressing tumor cells. Biochemical Pharmacology 2010 80 1 22 30 2-s2.0-77952266182 10.1016/j.bcp.2010.02.016
164. Li S., Ji Z., Zou M., Nie X., Shi Y., Cheng G., Preparation, characterization, pharmacokinetics and tissue distribution of solid lipid nanoparticles loaded with tetrandrine. AAPS PharmSciTech 2011 12 3 1011 1018 2-s2.0-79960882628 10.1208/s12249-011-9665-3
165. Tan Q., Liu S., Chen X., Design and evaluation of a novel evodiamine-phospholipid complex for improved oral bioavailability. AAPS PharmSciTech 2012 13 2 534 547
166. Tang J., Feng Y., Tsao S., Wang N., Curtain R., Wang Y., Berberine and Coptidis Rhizoma as novel antineoplastic agents: a review of traditional use and biomedical investigations. Journal of Ethnopharmacology 2009 126 1 5 17 2-s2.0-70349971732 10.1016/j.jep.2009.08.009
167. Chan E., Displacement of bilirubin from albumin by berberine. Biology of the Neonate 1993 63 4 201 208 2-s2.0-0027289251 (Pubitemid 23170617)
168. Chan T. Y. K., The prevalence use and harmful potential of some Chinese herbal medicines in babies and children. Veterinary and Human Toxicology 1994 36 3 238 240 2-s2.0-0028284826 (Pubitemid 24177993)
169. Dogra R. K. S., Khanna S., Shanker R., Immunotoxicological effects of piperine in mice. Toxicology 2004 196 3 229 236 2-s2.0-1242315419 10.1016/j.tox.2003.10.006 (Pubitemid 38221497)
170. Daware M. B., Mujumdar A. M., Ghaskadbi S., Reproductive toxicity of piperine in Swiss albino mice. Planta Medica 2000 66 3 231 236 2-s2.0-0034051961 10.1055/s-2000-8560 (Pubitemid 30235583)
171. Unchern S., Saito H., Nishiyama N., Selective cytotoxicity of piperine on cultured rat hippocampal neurons in comparison with cultured astrocytes: the possible involvement of lipid peroxidation. Biological and Pharmaceutical Bulletin 1997 20 9 958 961 2-s2.0-0030771247 (Pubitemid 27432867)
172. Choy C. S., Cheah K. P., Chiou H. Y., Li J. S., Liu Y. H., Yong S. F., Chiu W. T., Liao J. W., Hu C. M., Induction of hepatotoxicity by sanguinarine is associated with oxidation of protein thiols and disturbance of mitochondrial respiration. Journal of Applied Toxicology 2008 28 8 945 956 2-s2.0-55549096414 10.1002/jat.1360
173. Chan W. H., Embryonic toxicity of sanguinarine through apoptotic processes in mouse blastocysts. Toxicology Letters 2011 205 3 285 292 2-s2.0-79960907698 10.1016/j.toxlet.2011.06.018